1. Home
  2. URGN vs SHO Comparison

URGN vs SHO Comparison

Compare URGN & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

N/A

Current Price

$43.39

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

N/A

Current Price

$10.96

Market Cap

1.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
URGN
SHO
Founded
2004
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.8B
IPO Year
2016
2004

Fundamental Metrics

Financial Performance
Metric
URGN
SHO
Price
$43.39
$10.96
Analyst Decision
Strong Buy
Hold
Analyst Count
7
7
Target Price
$29.29
$9.79
AVG Volume (30 Days)
985.0K
2.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
3.66%
EPS Growth
N/A
N/A
EPS
N/A
0.22
Revenue
$1,128,000.00
$1,115,167,000.00
Revenue This Year
$129.09
$3.95
Revenue Next Year
$70.96
$2.30
P/E Ratio
N/A
$50.77
Revenue Growth
N/A
N/A
52 Week Low
$15.86
$8.69
52 Week High
$50.81
$12.07

Technical Indicators

Market Signals
Indicator
URGN
SHO
Relative Strength Index (RSI) 45.28 40.00
Support Level $18.25 $8.84
Resistance Level $43.93 $12.01
Average True Range (ATR) 1.82 0.23
MACD -0.90 0.01
Stochastic Oscillator 14.81 55.04

Price Performance

Historical Comparison
URGN
SHO

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

Share on Social Networks: